cyanocobalamin b12 injection Cyanocobalamin Injection, 2mg/mL | Olympia

Research context Community subcutaneous planning Amount or duration 300500 mcg per day Evidence level Anecdotal community standard Research context Published human trials Amount or duration Route and dose varied by study Evidence level Published research Research context Approved medical dosage Amount or duration None Evidence level AOD-9604 is not FDA-approved AOD-9604 Reconstitution Guide: How to Mix a 5 mg Vial A 5 mg AOD-9604 vial can be mixed with different amounts of bacteriostatic water

This allows researchers to isolate metabolic signaling effects without confounding endocrine responses, making AOD 9604 a useful model for studying localized metabolic regulation

[9] The doses in this compounded injection are much lower than those therapeutic megadoses, but still higher than typical dietary intake

suggesting that, at high concentrations, IGF-1 has effects not simply mediated by suppressing the effect of GH on hepatic insulin sensitivity [129, 209]